Estrogen Changes How Growth Hormone Peptides Work in Postmenopausal Women
Oral estradiol modulated GHRP-2's GH-stimulating effects in postmenopausal women, increasing IGF-1 response but altering GH pulsatile dynamics, revealing important sex hormone-GH peptide interactions.
Quick Facts
What This Study Found
Oral estradiol supplementation in postmenopausal women modulated continuous GHRP-2-driven GH secretion, increasing IGF-1 response but altering GH pulse dynamics, revealing estrogen-GH secretagogue interactions important for clinical dosing.
Key Numbers
How They Did This
Randomized study in 10 healthy postmenopausal women. Oral estradiol supplementation followed by 24-hour continuous GHRP-2 infusion with 10-minute blood sampling. GH deconvolution analysis and IGF-1 measurement.
Why This Research Matters
Millions of postmenopausal women use estrogen therapy and may also benefit from GH secretagogues. Understanding how these interact is essential for safe, effective combination therapy.
The Bigger Picture
Hormone therapies don't work in isolation. Estrogen's effects on the GH axis demonstrate that menopause management must consider how reproductive hormones affect other endocrine systems.
What This Study Doesn't Tell Us
Small study (10 women). Oral estradiol (which undergoes first-pass liver metabolism) may differ from transdermal estradiol in GH axis effects. Acute estrogen effects may not reflect chronic use.
Questions This Raises
- ?Does transdermal estradiol produce different GHRP-2 interactions?
- ?Should GH secretagogue doses be adjusted in women on estrogen?
- ?Does the route of estrogen administration matter for GH axis effects?
Trust & Context
- Key Stat:
- Estrogen modulates GHRP-2 Oral estradiol increased IGF-1 response to GHRP-2 but modified GH pulsatile dynamics in postmenopausal women
- Evidence Grade:
- Strong evidence from a well-designed study with intensive hormonal profiling in the relevant clinical population, limited by small sample size.
- Study Age:
- Published in 2000. The interaction between estrogen and GH secretagogues is recognized as clinically important, with route-of-administration effects further characterized.
- Original Title:
- Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
- Published In:
- The Journal of clinical endocrinology and metabolism, 85(8), 2649-59 (2000)
- Authors:
- Shah, N(4), Evans, W S(4), Bowers, C Y(21), Veldhuis, J D
- Database ID:
- RPEP-00617
Evidence Hierarchy
Frequently Asked Questions
Does estrogen affect how GH peptides work?
Yes. This study shows oral estrogen changes the pattern and magnitude of growth hormone response to GHRP-2 in postmenopausal women. Women on estrogen may need different GH peptide doses than those not taking estrogen.
Why does the estrogen route matter?
Oral estrogen passes through the liver first, which changes how it affects GH and IGF-1 production. Transdermal (patch) estrogen bypasses the liver and may interact differently with GH peptides.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00617APA
Shah, N; Evans, W S; Bowers, C Y; Veldhuis, J D. (2000). Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.. The Journal of clinical endocrinology and metabolism, 85(8), 2649-59.
MLA
Shah, N, et al. "Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.." The Journal of clinical endocrinology and metabolism, 2000.
RethinkPeptides
RethinkPeptides Research Database. "Oral estradiol administration modulates continuous intraveno..." RPEP-00617. Retrieved from https://rethinkpeptides.com/research/shah-2000-oral-estradiol-administration-modulates
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.